McGuinness OP; discussion 51S-53S et al.
The American journal of medicine, 89(2A), 26S-37S (1990-08-20)
Glyburide, along with the other second-generation oral hypoglycemic agent glipizide, has been used as adjunctive therapy for the treatment of non-insulin-dependent diabetes mellitus. After glyburide therapy, basal glycemia and glucose response to a meal are greatly improved. The mechanism for